Key facts
- This page summarizes Robin Kramer's Form 4 filing for BIOGEN INC. (BIIB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Feb 2024, 18:01.
Robin Kramer - 09 Feb 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- Chief Accounting Officer
- Issuer ticker
- BIIB
- Reported as of
- 09 Feb 2024
- Net transaction value
- -$59,040
- SEC form
- 4
- Accepted by SEC
- 13 Feb 2024, 18:01:55 UTC
- Prior SEC filing
- 09 Feb 2024
- Next SEC filing
- 21 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wendell Taylor, attorney-in-fact for Robin Kramer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robin Kramer filed Form 4 for BIOGEN INC. (BIIB) on 13 Feb 2024.
Change
- Previous filing in this sequence was filed on 09 Feb 2024.
- Current net transaction value: -$59,040.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +833
- Change %
- +18%
- Price
- $0.000000
- Shares after
- 5,523
- Date
- 09 Feb 2024
- Ownership
- Direct
BIIB
transaction
Common Stock
Tax liability
- Transaction value
- $59,040
- Shares
- -245
- Change %
- -4.4%
- Price
- $240.98
- Shares after
- 5,278
- Date
- 09 Feb 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIIB
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -833
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 834
- Date
- 09 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 833
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.